Description
Overview
This research blend combines Semaglutide (5mg) with Tesofensine (500mcg). Tesofensine is a triple monoamine reuptake inhibitor that has been studied for its effects on appetite and metabolism.
Research Applications
- Appetite regulation studies
- Dual-mechanism metabolic research
- Neurotransmitter pathway investigations
- Combination therapy studies
Specifications
- Semaglutide: 5mg per tablet
- Tesofensine: 500mcg per tablet
- Count: 30 tablets
- Form: Oral research tablet
- Storage: Room temperature, dry conditions
Reviews
There are no reviews yet.